Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Malignant function of nuclear factor-kappaB axis in prostate cancer: Molecular interactions and regulation by non-coding RNAs.
Al-Rashidi RR, Noraldeen SAM, Kareem AK, Mahmoud AK, Kadhum WR, Ramírez-Coronel AA, Iswanto AH, Obaid RF, Jalil AT, Mustafa YF, Nabavi N, Wang Y, Wang L. Al-Rashidi RR, et al. Among authors: nabavi n. Pharmacol Res. 2023 Aug;194:106775. doi: 10.1016/j.phrs.2023.106775. Epub 2023 Apr 17. Pharmacol Res. 2023. PMID: 37075872 Free article. Review.
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents.
Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P, Gholami S, Ghorbani A, Tavakolpournegari A, Farsani ZM, Zarrabi A, Nabavi N, Zandieh MA, Rashidi M, Taheriazam A, Entezari M, Khan H. Hashemi M, et al. Among authors: nabavi n. Pharmacol Res. 2023 Jan;187:106568. doi: 10.1016/j.phrs.2022.106568. Epub 2022 Nov 21. Pharmacol Res. 2023. PMID: 36423787 Free article. Review.
PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation.
Rezaei S, Nikpanjeh N, Rezaee A, Gholami S, Hashemipour R, Biavarz N, Yousefi F, Tashakori A, Salmani F, Rajabi R, Khorrami R, Nabavi N, Ren J, Salimimoghadam S, Rashidi M, Zandieh MA, Hushmandi K, Wang Y. Rezaei S, et al. Among authors: nabavi n. Eur J Pharmacol. 2023 Sep 15;955:175909. doi: 10.1016/j.ejphar.2023.175909. Epub 2023 Jul 23. Eur J Pharmacol. 2023. PMID: 37490949 Review.
Doxorubicin-loaded micelles in tumor cell-specific chemotherapy.
Almajidi YQ, Kadhim MM, Alsaikhan F, Turki Jalil A, Hassan Sayyid N, Alexis Ramírez-Coronel A, Hassan Jawhar Z, Gupta J, Nabavi N, Yu W, Ertas YN. Almajidi YQ, et al. Among authors: nabavi n. Environ Res. 2023 Jun 15;227:115722. doi: 10.1016/j.envres.2023.115722. Epub 2023 Mar 21. Environ Res. 2023. PMID: 36948284 Review.
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies.
Hashemi M, Abbaszadeh S, Rashidi M, Amini N, Talebi Anaraki K, Motahhary M, Khalilipouya E, Harif Nashtifani A, Shafiei S, Ramezani Farani M, Nabavi N, Salimimoghadam S, Aref AR, Raesi R, Taheriazam A, Entezari M, Zha W. Hashemi M, et al. Among authors: nabavi n. Environ Res. 2023 Sep 15;233:116458. doi: 10.1016/j.envres.2023.116458. Epub 2023 Jun 20. Environ Res. 2023. PMID: 37348629 Review.
Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells.
Yenki P, Bhasin S, Liu L, Nabavi N, Cheng CW, Tam KJ, Peacock JW, Adomat HH, Tombe T, Fazli L, Ivanova L, Dusek C, Khosravi S, Guns EST, Wang Y, Buttyan R, Gleave ME, Ong CJ. Yenki P, et al. Among authors: nabavi n. Endocr Relat Cancer. 2023 Nov 6;30(12):e230010. doi: 10.1530/ERC-23-0010. Print 2023 Dec 1. Endocr Relat Cancer. 2023. PMID: 37800655 Free PMC article.
Role of non-coding RNAs in osteoporosis.
Baniasadi M, Talebi S, Mokhtari K, Zabolian AH, Khosroshahi EM, Entezari M, Dehkhoda F, Nabavi N, Hashemi M. Baniasadi M, et al. Among authors: nabavi n. Pathol Res Pract. 2024 Jan;253:155036. doi: 10.1016/j.prp.2023.155036. Epub 2023 Dec 13. Pathol Res Pract. 2024. PMID: 38134836 Review.
Investigating the interplay between mitophagy and diabetic neuropathy: Uncovering the hidden secrets of the disease pathology.
Hushmandi K, Einollahi B, Aow R, Suhairi SB, Klionsky DJ, Aref AR, Reiter RJ, Makvandi P, Rabiee N, Xu Y, Nabavi N, Saadat SH, Farahani N, Kumar AP. Hushmandi K, et al. Among authors: nabavi n. Pharmacol Res. 2024 Oct;208:107394. doi: 10.1016/j.phrs.2024.107394. Epub 2024 Sep 3. Pharmacol Res. 2024. PMID: 39233055 Free article. Review.
Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications.
Hashemi M, Fard AA, Pakshad B, Asheghabadi PS, Hosseinkhani A, Hosseini AS, Moradi P, Mohammadbeygi Niye M, Najafi G, Farahzadi M, Khoushab S, Taheriazam A, Farahani N, Mohammadi M, Daneshi S, Nabavi N, Entezari M. Hashemi M, et al. Among authors: nabavi n. Noncoding RNA Res. 2024 Dec 3;11:1-21. doi: 10.1016/j.ncrna.2024.11.006. eCollection 2025 Apr. Noncoding RNA Res. 2024. PMID: 39720352 Free PMC article. Review.
161 results